The ROE as of December 2025 (TTM) for Concert Pharmaceuticals, Inc. (CNCE) is -67.87%

According to Concert Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -67.87%. This represents a change of 291.84% compared to the average of -17.32% of the last 4 quarters.

Concert Pharmaceuticals, Inc. (CNCE) Historical ROE (quarterly & annually)

How has CNCE ROE performed in the past?

The mean historical ROE of Concert Pharmaceuticals, Inc. over the last ten years is -26.55%. The current -67.87% ROE has changed 155.60% with respect to the historical average. Over the past ten years (40 quarters), CNCE's ROE was at its highest in in the September 2017 quarter at 65.39%. The ROE was at its lowest in in the September 2013 quarter at -112.68%.

Concert Pharmaceuticals, Inc. (CNCE) ROE by Quarter and Year

Discovering the peaks and valleys of Concert Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Concert Pharmaceuticals, Inc. (CNCE) Average ROE

How has CNCE ROE performed in the past?

The current ROE of Concert Pharmaceuticals, Inc. (CNCE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Concert Pharmaceuticals, Inc. (CNCE) ROE vs. Peers

How is CNCE’s ROE compared to its peers?

Concert Pharmaceuticals, Inc.’s ROE is greater than Orchard Therapeutics plc (-5.12%), less than Revance Therapeutics, Inc. (49.59%), greater than Vigil Neuroscience, Inc. (-138.30%), less than Checkpoint Therapeutics, Inc. (916.24%), greater than iTeos Therapeutics, Inc. (-35.52%), greater than Climb Bio, Inc. (-23.10%), greater than G1 Therapeutics, Inc. (-92.13%), greater than Y-mAbs Therapeutics, Inc. (-24.60%), greater than SomaLogic, Inc. (-18.59%), greater than scPharmaceuticals Inc. (-2086.11%),

Build a custom stock screener for Concert Pharmaceuticals, Inc. (CNCE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Concert Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Concert Pharmaceuticals, Inc. (CNCE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Concert Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.